Alzheimer Disease: New Concepts on Its Neurobiology and the Clinical Role Imaging Will Play
Top Cited Papers
- 1 May 2012
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 263 (2), 344-361
- https://doi.org/10.1148/radiol.12110433
Abstract
At present, the most well developed Alzheimer disease biomarkers are the cerebrospinal fluid analytes amyloid-β?42 residue and tau and the brain imaging measures amyloid PET, fluorodeoxyglucose PET... Alzheimer disease (AD) is one of, if not the most, feared diseases associated with aging. The prevalence of AD increases exponentially with age after 60 years. Increasing life expectancy coupled wi...Keywords
This publication has 278 references indexed in Scilit:
- Amyloid‐beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B dataAnnals of Neurology, 2011
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Alzheimer Disease and Cognitive ReserveArchives of Neurology, 2008
- Neuropathological basis of magnetic resonance images in aging and dementiaAnnals of Neurology, 2007
- Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive ImpairmentArchives of Neurology, 2007
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004